News Agency

QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours

  • Written by PR Newswire
  • STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary Medicine for the treatment of non-metastatic mast cell tumours (MCT) in dogs, making it the first pharmaceutical treatment available for all grades of canine non-metastatic MCT[1]
  • FDA approval follows the early 2020 marketing...

Read more: QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours

AMOLED Display Technology: Advantages and Applications

Introduction AMOLED (Active Matrix Organic Light-Emitting Diode, active matrix organic light-emitting diode) display technology is one of the important innovations in today’s display field. Compared with traditional LCD (liquid crystal display), AMOLED displays have many unique advantages and have been widely... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion